HMD vs RGT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

HMD

HERAMED FPO [HMD]

44LOW

RGT

ARGENTBIO FPO [RGT]

44LOW

Score Breakdown

HMD RGT
Technical
49
61
Catalyst
55
51
Sentiment
50
50
Fundamental
33
34
Momentum
54
50
Risk Gate
37
37

Key Metrics

HMD Metric RGT
$45.2MMarket Cap$6.9M
650KAvg Volume (20d)1.2M
N/AShort InterestN/A
$0.05552-Week High$0.320
$0.01152-Week Low$0.033
-7.7%Daily Change-1.7%
$0.036Entry Price$0.058
-223.2%ROEN/A
N/AProfit MarginN/A

Active Signals

HMD Signals

RSI drifting toward oversold territory — worth watching
Took a hit — down 14.3% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Very high P/S ratio (104.7x)
Piotroski F-Score weak (3/9, low-confidence approx)
Small-cap ($20-100M)

RGT Signals

Trading above both moving averages — the trend is your friend here
Volume surging at 13.2x normal while price climbs — real buying conviction behind this move
Took a hit — down 14.7% over the last 5 days
Beating the Small Ords index — relative strength of 1.68, so it's outpacing the pack
Volatility is expanding fast — choppy price action, so buckle up
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (0.8 quarters)
Strong revenue growth (+3905%)

Ask Scout AI to compare HMD and RGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HMD Full Analysis → RGT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).